Agilent Technologies Inc.
(NYSE: A) today announced the appointments of Robert Schueren as vice president
and general manager, Genomics; and John Fjeldsted, Ph.D., as general manager,
Liquid Chromatography/Mass Spectrometry.
"The life sciences and biological systems business continues to be a key
growth driver for Agilent, and the addition of Robert and John strengthens our
current leadership team and positions us well for future success," said
Gustavo Salem, vice president and general manager of Agilent's Biological Systems
Division.
Schueren will be responsible for all genomics operations, including microarrays,
QPCR and life science reagents. Most recently, he was global head of companion
diagnostics, clinical biomarker, and sample operations at Genentech/Roche. During
his time at Genentech/Roche, Schueren provided strategic leadership in diagnostic-related
fields, established multiple external collaborations, led Roche and Genentech
integration teams, and streamlined multiple operating groups.
Fjeldsted will be responsible for managing the LC/MS business and driving market
share in high-end LC/MS. He has been with Agilent for more than 25 years and
played a key role in the tremendous growth of Agilent's LC/MS unit. Most recently,
he served as R&D manager for LC/MS as Agilent entered the LC/MS business
with triple quadrupole and QTOF mass spectrometers.
Additionally, George Stafford has joined Agilent as LC/MS hardware R&D
manager. Most recently, Stafford held the position of R&D program manager,
responsible for Thermo Fisher Scientific's LC/MS research programs and university
collaborations. Stafford has made countless contributions in various capacities
over many years while at Finnigan, Thermo Instruments and Thermo Fisher Scientific.
His experience includes fundamental work in negative ion detection to research
and product development in ion trap mass spectrometry; ionization and ion dissociation
developments; and hybrid instrumentation research.
"To most of us in the LC/MS community, George is well known and respected
for his thought leadership, creativity and insight over the past few decades,"
added Salem.